Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

Loïc Reppel(University of North Carolina at Chapel Hill), Barbara Savoldo(University of North Carolina at Chapel Hill)

Journal for ImmunoTherapy of Cancer

January 1, 2022

10.1136/jitc-2021-003897

Cited by 72

Related Papers

Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

|Blood|2014|738

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model

|Blood|2009|523

Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes

|Journal of Clinical Investigation|2017|368

T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>

|Clinical Cancer Research|2013|100